864866-77-3

Basic information

• Product Name: N-methyl-2-amino-4-bromobenzamide
• Synonyms: N-methyl-2-amino-4-bromobenzamide
• CAS NO: 864866-77-3
• Molecular Weight: 229.076
• Mol File: 864866-77-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-methyl-2-amino-4-bromobenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-methyl-2-amino-4-bromobenzamide(864866-77-3)
• EPA Substance Registry System: N-methyl-2-amino-4-bromobenzamide(864866-77-3)

Safety Data

• Hazardous Substances Data: 864866-77-3(Hazardous Substances Data)

Upstream product

• 1261666-37-8 C₇H₅BrClNO 
• 74-89-5 methylamine 
• 20776-50-5 2-amino-4-bromobenzoic acid 
• 76561-16-5 7-bromo-1,2-dihydro-3,1-4H-benzoxazine-2,4-dione 

Downstream Products

• 1312453-66-9 4-bromo-2-(3-methoxypropanamido)-N-methylbenzamide 

Relevant articles and documents

Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof

The present invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth.

COMBINATION OF KINASE INHIBITORS AND USES THEREOF

The present invention provides for a method for treating a disease condition associated with PI3-kinase a and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase a and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth. The present invention also provides a pharmaceutical kit effective for treating a disease condition associated with PI3 -kinase α and/or mTOR in a subject.